Exhibit 23.2

               Consent of Ernst & Young LLP, Independent Auditors






                                                                    EXHIBIT 23.2


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statement (Form
S-8) pertaining to the 1992 Stock Option / Stock Issuance Plan and the 1992
Employee Stock Purchase Plan of Ligand Pharmaceuticals Incorporated of our
report dated February 22, 2000, with respect to the consolidated financial
statements of Ligand Pharmaceuticals Incorporated included in its Annual Report
on Form 10-K for the year ended December 31, 2000, filed with the Securities and
Exchange Commission.




                                                        /s/ Ernst & Young LLP


San Diego, California
July 27, 2001